This Diabetes Company's Q1 Earnings Reflect the Resiliency of Its Business Model

This Diabetes Company's Q1 Earnings Reflect the Resiliency of Its Business Model

The COVID-19 pandemic is presenting a headwind, but Insulet's recurring-revenue-generating business model helps insulate it.